Antiviral Therapeutics Market
Antiviral Therapeutics Market: By Type - (Generic and Branded); By Drug Type - (Herpes Antiviral Drugs, Hepatitis Antiviral Drugs, HIV Antiviral Drugs, Influenza Antiviral Drugs, and Others Antiviral Drugs); By Distribution Channel - (Hospital Pharmacy, RRequest Sample Request Discount
The antiviral therapeutics market is anticipated to flourish at a CAGR of 5.8% over the forecast period i.e. 2020-2025. Further, the market for antiviral therapeutics was valued at USD XXX.X million in 2019.
Growth Drivers – Antiviral Therapeutics Market
Increasing Prevalence of HIV Infection
Rising prevalence of HIV and hepatitis C infections across the globe is resulting in increased demand for antiviral therapeutics. According to the World Health Organization, in 2020, 37.9 Million were living with HIV in the world. Further, according to another WHO report, an estimated 71 million people are suffering from chronic hepatitis C virus infection. Antiviral drugs can treat more than 95% of hepatitis C patients. However, lack of access to diagnosis and treatment is resulting in low treatment ratio. Further, various healthcare organizations and governments are working on reducing the death rate and providing healthcare access to people. This factor is anticipated to strengthen the growth of global antiviral therapeutics market during the forecast period.
Launch of New Drugs
Various leading pharmaceutical companies are focusing on the introduction of new and effective drugs in the market. Furthermore, upcoming patent expiry of few drugs is anticipated to increase the flow of generic drugs in the market. These factors are envisioned to bolster the growth of antiviral therapeutics market.
Barriers – Antiviral Therapeutics Market
High Cost of Therapeutic Treatment
Factors such as high cost of antiviral drug treatment are hindering the growth of global antiviral therapeutics. Moreover, the growing use of natural products and the high cost of developing drugs is also acting as a restraint for global antiviral therapeutics market.
The antiviral therapeutics market by type is segmented into generic and branded. The market for generic captured the highest percentage in 2020. Moreover, it is anticipated to continue its dominance during the forecast period. In drug type segment, HIV antiviral drugs segment is anticipated to capture the largest percentage share of the market.
Further, global antiviral therapeutics market is also segmented by distribution channel into hospital pharmacy, retail pharmacy store, and online pharmacy. Retail pharmacy segment captured high market share during the forecast period. However, online pharmacy is anticipated to witness the highest growth in the upcoming years. Factors such as increasing penetration of internet and rising online pharmacies across the world are anticipated to bolster the growth of antiviral drugs online retailing market.
Geographically, the report offers an analysis of North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In the antiviral therapeutics market, North America accounted for the largest percentage of the market in global antiviral therapeutics market. Increasing prevalence of HIV infections and hepatitis C in North America is anticipated to further drive the growth of North America antiviral therapeutics market. According to U.S. Department of Health & Human Services, about 1.1 million people were living with HIV in 2017. Moreover, around 38,700 new patients were diagnosed in 2016. This factor is anticipated to pave the way for the growth of North America antiviral therapeutics market. Asia Pacific antiviral therapeutics market is anticipated to witness robust growth during the forecast period. Increasing base of the target population and the rising presence of leading pharmaceutical companies is anticipated to impel the growth of Asia Pacific antiviral therapeutics market.
The report profiles various major market players such as
- AbbVie Inc.
- Bristol-Meyrs Squibb Company
- Cipla Inc.
- F. Hoffmann-La Roche Ltd
- Gilead Sciences Inc
- GlaxoSmithKline Plc
- Johnson & Johnson
- Merck & Co. Inc.
- Pfizer Inc.
- Other Major & Niche Players
Competitive landscape analysis provides detailed strategic analysis of the company’s business and performance such as financial information, revenue breakup by segment and by geography, SWOT Analysis, key facts, company overview, business strategy, key product offerings, marketing and distribution strategies, new product development, recent news (acquisition, expansion, technology development, research & development and other market activities).
The study also provides a company’s positioning and market share in antiviral therapeutics market.
Timeline Considered for Analysis:
- 2019: Base Year
- 2020: Estimated Year
- 2020 to 2025: Forecasted Year
Research Scope and Deliverables
Overview & Executive Summary
Market Drivers, Trends, Challenges and Opportunities
Market Size and Forecast Projections
Macroeconomic Indicators of Various Countries Impacting the Growth of the Market
Extensive Coverage of Industry Players including Recent Product Launches and Market Activities
Porter’s Five Force Analysis
Market Segmentation Analysis:
Industry report analyzes the global antiviral therapeutics market by the following segments:
- Drug Type
- Distribution Channel
Customization: We also offers customization’s in the industry report as per the company’s specific needs.
Key Questions Answered in the Global Antiviral Therapeutics Industry Report
• What is the overall market size in 2019? What will be the market growth during the forecast period i.e. 2020-2025?
• Which region would have a high demand for a product in the upcoming years?
• What are the factors driving the growth of the market?
• Which sub-market will make the most significant contribution to the market?
• What are the market opportunities for existing and entry-level players?
• What are various long-term and short-term strategies adopted by the market players?
Custom Research Requirement? Questions to ask?Get in touch
Custom Research requirement.